COVID-19 Rapid Diagnostic Throat Test Kits OEM 95.52% Sensitivity

Certification:CE; ISO
Minimum Order Quantity:10-100pcs
Delivery Time:3-5working days
Place of Origin:Beijing
Price:USD1.8-3.5/pc
Supply Ability:1million per week
Contact Now

Add to Cart

Active Member
Location: Wuxi Jiangsu China
Address: Huafa Mansion, Binhu District, Wuxi, Jiangsu Province, China
Supplier`s last login times: within 35 hours
Product Details Company Profile
Product Details

ISO Rapid Diagnostic Throast Test Kits Certificated with CE Antigen Test for fresh swabs COVID-19 Antigen China OEM


PERFORMANCE CHARACTERCS

The assay demonstrated excellent clinical specificity 100% (95% CI: 93.98%-100%). Overall Agreement was 97.64% (93.28%-99.19%). The assay demonstrated acceptable total clinical sensitivity is 91.08% (95% CI: 85.59%-94.61%) when compared to a molecular device produced by Sansure Inc. The assay demonstrated excellent clinical specificity 100% (95% CI: 98.54%-100%). Overall Agreement was 96.64% (94.44%-97.99%).


Overall Clinical Performance of Antigen Test Kit

A total of above 157 positive samples and 260 negative samples were detected to evaluate the clinical performance of the COVID-19 Antigen Rapid Test Kit. The Result is below:

Sansure Covid-19 RT-PCR Assay
PositiveNegativeTotal
Kewei COVID-19 Antigen Rapid AssayPositive1430143
Negative14260274
Total157260417

The assay demonstrated acceptable total clinical sensitivity is 91.08% (95% CI: 85.59%-94.61%) when compared to a molecular device produced by Sansure Inc. The assay demonstrated excellent clinical specificity 100% (95% CI: 98.54%-100%). Overall Agreement was 96.64% (94.44%-97.99%).

Limit of Detection(LoD)

Limit of detection (LoD) was determined by evaluating different concentrations of heat inactivated SARS-CoV-2 virus. LoD of the SARS-CoV-2 antigen rapid kit was confirmed as 38.5 TCID50/ml.

High-dose Hook effect

No high dose hook effect was observed when test with up to a concentration of 6.3×105 TCID50/ml of heat inactive SARS-CoV-2 virus from Academy of Military Sciences PLA China.


Cross Reactivity

Many types of pneumonia are companied by fever, cough and other respiratory symptoms. In order to eliminate similar clinical symptoms of other types of pneumonia effects, pneumonia mycoplasma, influenza A, pneumococcus etc. were detected for the specific assessment. Each of the organism and viruses were tested in the absence or presence of heat inactivated SARS-CoV-2 virus (308 TCID50/ml), No cross-reactivity or interference was seen.

Potential Cross-ReactantTest ConcentrationResult
Absence of SARS-CoV-2presence of SARS-CoV-2
Staphylococcus aureus1.0×105 TCID50/ml+
Streptococcus pneumoniae1.0×106 Cells/ml+
Measles virus1.0×105 TCID50/ml+
Mumps virus1.0×105 TCID50/ml+
Adenovirus type 31.0×105 TCID50/ml+
Mycoplasma pneumoniae MP1.0×106 Cells/ml+
Parainfluenza type 21.0×105 TCID50/ml+
Metapneumovirus1.0×105 TCID50/ml+
Coronavirus OC431.0×105 TCID50/ml+
Coronavirus 229E1.0×105 TCID50/ml+
Bordetella parapertussis1.0×106 Cells/ml+
Influenza B virus (Victoria series)1.0×105 TCID50/ml+
Influenza B virus (Y series)1.0×105 TCID50/ml+
Influenza A H1N1 (2009) virus1.0×105 TCID50/ml+
Influenza A H3N2 virus1.0×105 TCID50/ml+
Avian influenza virus H7N91.0×105 TCID50/ml+
Avian influenza virus H5N11.0×105 TCID50/ml+
EB virus1.0×105 TCID50/ml+
Enterovirus CA161.0×105 TCID50/ml+
Rhinovirus1.0×105 TCID50/ml+



China COVID-19 Rapid Diagnostic Throat Test Kits OEM 95.52% Sensitivity supplier

COVID-19 Rapid Diagnostic Throat Test Kits OEM 95.52% Sensitivity

Inquiry Cart 0